Teva Pharmaceutical Industries Limited (TEV) — Cash Flow Reinvestment Rate
Teva Pharmaceutical Industries Limited (TEV) has a Cash Flow Reinvestment Rate of 0.14x as of December 2025, reinvesting €167.00 Million (capex €142.00 Million plus investments €25.00 Million) from operating cash flow of €1.16 Billion. Check TEV operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Teva Pharmaceutical Industries Limited Cash Flow Reinvestment Rate (2015–2025)
Historical reinvestment intensity for Teva Pharmaceutical Industries Limited across 11 annual periods. Explore long-term investment intensity of Teva Pharmaceutical Industries Limited to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Teva Pharmaceutical Industries Limited (2015–2025)
Year-by-year capital reinvestment analysis for Teva Pharmaceutical Industries Limited. For live market cap and broader valuation context, see market value of Teva Pharmaceutical Industries Limited.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.31x | €516.00 Million | €1.65 Billion | €501.00 Million | ▼ -26.2% |
| 2024 | 0.42x | €529.00 Million | €1.25 Billion | €498.00 Million | ▼ -64.5% |
| 2023 | 1.20x | €1.38 Billion | €1.16 Billion | €549.00 Million | ▲ +245.2% |
| 2022 | 0.35x | €551.00 Million | €1.59 Billion | €548.00 Million | ▼ -59.7% |
| 2021 | 0.86x | €687.00 Million | €798.00 Million | €562.00 Million | ▲ +68.6% |
| 2020 | 0.51x | €621.00 Million | €1.22 Billion | €578.00 Million | ▼ -28.1% |
| 2019 | 0.71x | €531.00 Million | €748.00 Million | €525.00 Million | ▲ +125.5% |
| 2018 | 0.31x | €770.00 Million | €2.45 Billion | €651.00 Million | ▼ -34.8% |
| 2017 | 0.48x | €1.07 Billion | €2.23 Billion | €874.00 Million | ▼ -94.9% |
| 2016 | 9.42x | €36.64 Billion | €3.89 Billion | €901.00 Million | ▲ +1781.1% |
| 2015 | 0.50x | €2.77 Billion | €5.54 Billion | €772.00 Million | — |